Skip to main content
Caplight Logo









Stemmatters

Stemmatters

Private
GuimarãesHealthcare & Life Scienceshttps://stemmatters.com/

Last Round

Grant

Nov 25, 2025

Total Funding Raised

$2.36M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Stemmatters is a biotechnology company that operates as a contract development and manufacturing organization (CDMO) specializing in regenerative medicine, advanced cell therapies, and biological products.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Advanced Materials, Clinical Trials, Drug Discovery, Quality Management

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share

AI Layer

Non-AI

Keywords

contract development and manufacturing organizationCDMOregenerative medicineadvanced therapy medicinal productsATMPcGMP manufacturingbiomaterial platformcell therapy manufacturingcell bankingbiotech outsourcingprocess developmentanalytical servicesformulation developmentclinical translationbiotech manufacturing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Stemmatters Comparables

Compare Stemmatters with similar companies based on industry and business-model similarity.

Stemmatters comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Cellab CDMO
88%
Histocell
87%
HiTech Health
85%

Stemmatters Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantNov 25, 2025
GrantJun 22, 2023
GrantOct 1, 2022
GrantApr 15, 2022
Series ASep 16, 2011

Stemmatters Investors

Notable investors and investment history

Stemmatters investors
InvestorRounds
European Innovation Council FundGrant
Caixa CapitalSeries A
Eurostars SME programmeGrant
Beta CapitalSeries A
PathenaSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 21, 2026

    Grew 18% QoQ, from 39 to 46 employees.

  • May 17, 2026

    Monthly visitors increased 217% MoM.

Stemmatters Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Stemmatters Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Stemmatters's valuation, stock price, and market status.

Firmographic Details

HeadquartersGuimarães
Employee Range44
Year Founded2007
Last FundingNov 25, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?